Viread and Nephropathy toxic - a phase IV clinical study of FDA data

Summary:

Nephropathy toxic is reported as a side effect among people who take Viread (tenofovir disoproxil fumarate), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Epivir, and have Lung adenocarcinoma.

The phase IV clinical study analyzes which people have Nephropathy toxic when taking Viread. It is created by eHealthMe based on reports of 51,434 people who have side effects when taking Viread from the FDA, and is updated regularly.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

What is Nephropathy toxic?

Nephropathy toxic (damage to kidney due to toxins) is found to be associated with 597 drugs and 739 conditions by eHealthMe. Check the latest studies of Nephropathy toxic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

51,434 people reported to have side effects when taking Viread.
Among them, 135 people (0.26%) have Nephropathy toxic.

Among these 135 people:

* Approximation only. Some reports may have incomplete information.

Do you take Viread and have Nephropathy toxic?

- Check whether Nephropathy toxic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viread:

Viread (51,542 reports)

Nephropathy toxic treatments and more:

Nephropathy toxic (11,394 reports)

How severe was Nephropathy toxic and when was it recovered:

Nephropathy toxic in Viread

Expand to all the drugs that have ingredients of tenofovir disoproxil fumarate:

Nephropathy toxic and drugs with ingredients of tenofovir disoproxil fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephropathy toxic:

Nephropathy toxic (597 drugs)

Browse all the conditions that are associated with Nephropathy toxic:

Nephropathy toxic (739 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate (the active ingredients of Viread) and Viread (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.